Antimalarial multi-drug resistance in Asia: mechanisms and assessment.
about
Ocular fundus manifestation of two patients following long-term chloroquine therapy: a case reportTargeting Plasmodium falciparum Hsp90: Towards Reversing Antimalarial ResistanceProbing the multifactorial basis of Plasmodium falciparum quinine resistance: Evidence for a strain-specific contribution of the sodium-proton exchanger PfNHEMolecular surveillance for drug-resistant Plasmodium falciparum in clinical and subclinical populations from three border regions of Burma/Myanmar: cross-sectional data and a systematic review of resistance studiesIdentification and optimization of an aminoalcohol-carbazole series with antimalarial properties.Molecular markers of anti-malarial drug resistance in Central, West and East African children with severe malaria.In vitro sensitivity of Plasmodium falciparum clinical isolates from the China-Myanmar border area to quinine and association with polymorphism in the Na+/H+ exchanger.The aminopeptidase inhibitor CHR-2863 is an orally bioavailable inhibitor of murine malaria.Establishment of a large semi-field system for experimental study of African malaria vector ecology and control in Tanzania.Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.Parasite-host interaction in malaria: genetic clues and copy number variation.Trafficked Proteins-Druggable in Plasmodium falciparum?NF-κB Signaling Activation Induced by Chloroquine Requires Autophagosome, p62 Protein, and c-Jun N-terminal Kinase (JNK) Signaling and Promotes Tumor Cell Resistance.Antimalarial drug sensitivity profile of western Kenya Plasmodium falciparum field isolates determined by a SYBR Green I in vitro assay and molecular analysis.Decreasing pfmdr1 copy number in plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin.Re-evaluation of how artemisinins work in light of emerging evidence of in vitro resistance.
P2860
Q21203672-3BBF0082-AC05-4B5A-9540-F9A8F592F79BQ26864290-BDF092B6-C2C2-48AE-8A76-A92D0C7BCE44Q27861959-F8CE61D0-02BF-4B07-9DA6-5557DB0CF5B9Q30568502-09F3FE65-F98B-4A40-90D6-BF92D283FC3CQ33636074-8890C7A3-095D-4702-A42B-24BC4A0C60C2Q33721915-6BBA67C5-7D2E-4A4B-B31B-D34AEF268598Q34151002-A4523F66-A807-47D6-BEF3-CC3147BDE251Q36018855-4A890053-ED57-4548-BD6C-1D088AB02D46Q36891424-E964611B-F8D6-4F52-9E4A-6AE1083302CEQ37285721-EF6BD22F-66DE-44B5-AE0A-4DF02522EBE1Q37402635-5394CDBB-426F-428B-82D9-AFD196BF7AD0Q38109627-64EF444E-CE91-4CE0-91EF-33570F31A6FDQ38721544-1F852D71-F4C4-4366-8CCD-D60C7DA11B4EQ41932353-26E34EB7-DBC1-4204-ABA2-AD365E051120Q41944932-39F978F7-D4EC-4972-B541-47FA0DB209C0Q43127250-716162B0-FB2C-40B9-843B-26C41266E49E
P2860
Antimalarial multi-drug resistance in Asia: mechanisms and assessment.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Antimalarial multi-drug resistance in Asia: mechanisms and assessment.
@ast
Antimalarial multi-drug resistance in Asia: mechanisms and assessment.
@en
type
label
Antimalarial multi-drug resistance in Asia: mechanisms and assessment.
@ast
Antimalarial multi-drug resistance in Asia: mechanisms and assessment.
@en
prefLabel
Antimalarial multi-drug resistance in Asia: mechanisms and assessment.
@ast
Antimalarial multi-drug resistance in Asia: mechanisms and assessment.
@en
P1476
Antimalarial multi-drug resistance in Asia: mechanisms and assessment.
@en
P2093
A C Uhlemann
P577
2005-01-01T00:00:00Z